Manufacturer
129 recalls in our database name KRS Global Biotechnology, Inc as the manufacturing or recalling firm.
Of the 129 recalls from KRS Global Biotechnology, Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 73 (57%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
KRS Global Biotechnology is recalling 345 vials of Hydroxocobalamin 30 mg/30 mL for IM use due to a lack of assurance of sterility.
KRS Global Biotechnology is recalling 402 vials of Glutathione 30 mL due to a lack of assurance of sterility. The product was distributed nationwide.
KRS Global Biotechnology is recalling 345 vials of Hydroxocobalamin 10 mg/20 mL due to a lack of assurance of sterility. The recall covers all lots remaining within expiry and is distributed nationwide.
KRS Global Biotechnology is recalling 120 vials of Sermorelin and GHRP-2 because the company cannot assure the products are sterile.
The FDA is recalling 6,405 units of Labetalol HCl single-dose syringes because there was insufficient assurance of sterility during production. No illnesses or injuries have been reported.
KRS Global Biotechnology is recalling 190 bags of Repinephrine 16 mg IV solution due to a label mix-up. The product was distributed nationwide.
KRS Global Biotechnology is recalling 433 bags of NORepinephrine 4 mg in 5% Dextrose due to a label mix-up. The product was distributed nationwide.
KRS Global Biotechnology is recalling 122 vials of QUADMIX #17 because the product's beyond-use date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 40 jars of Iodochlorhydroxyquin Otic Powder because the Beyond Use Date exceeds the expiration of at least one ingredient.
KRS Global Biotechnology is recalling 100 jars of Chloramphenicol Otic Powder because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 1,203 vials of Human Chorionic Gonadotropin due to incorrect or missing lot and expiration dates.
KRS Global Biotechnology is recalling 1,380 jars of Benzocaine, Lidocaine, and Tetracaine Topical Cream because the product's beyond-use date exceeds the expiration dates of its ingredients.
KRS Global Biotechnology is recalling 2,274 vials of Human Chorionic Gonadotropin 20,000 iu due to incorrect or missing lot and expiration dates.
KRS Global Biotechnology is recalling 173 vials of T-105 because the Beyond Use Date exceeds the expiration of at least one ingredient.
KRS Global Biotechnology is recalling 81 droptainers of a multi-dose ophthalmic solution because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 3,000 Prednisolone 10 mg tablets because the expiration date exceeds the stability of an ingredient.
KRS Global Biotechnology is recalling Anastrozole SR 1 mg capsules because the Beyond Use Dates exceed the expiration dates of some ingredients.
KRS Global Biotechnology is recalling 3,280 jars of Benzo/Lido/Tetracaine 20%-8%-8% Topical Cream because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 6,414 vials of Human Chorionic Gonadotropin because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 4,530 jars of Benzocaine 20%, Lidocaine 6%, Tetracaine 4% Cream because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 2,535 vials of Nicotinamide Adenine Dinucleotide 500 mg because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 2,239 Human Chorionic Gonadotropin tablets because the expiration date exceeds the shelf life of an ingredient.
KRS Global Biotechnology is recalling 300 jars of Progesterone 3% Topical Cream because the Beyond Use Date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling Savinase 100 mcg/mL Topical Solution because the product's beyond-use date exceeds the expiration date of at least one ingredient.
KRS Global Biotechnology is recalling 80 vials of Amphotericin Otic Powder because the Beyond Use Date exceeds the expiration of at least one ingredient.